The impact of COVID-19 on patients with stroke
| Reference## | Delayed treatment (alteplase/thrombolysis/thrombectomy/consultation) | Thrombotic/ blood and immune system complications | NIHSS (stroke severity) | mRS (disability) | Mortality | The D-dimer levels | Comorbidities | ARDS | Prolonged hospitalization |
|---|---|---|---|---|---|---|---|---|---|
| [17] | *⋁ | *⋁ | *⋁ | *⋁ | |||||
| [36] | *⋁ | *⋁ | *⋁ | ||||||
| [18] | ***⋁ | ***⋁ | ***⋁ | ||||||
| [31] | ****⋁ | ****⋁ | ****⋁ | ****⋁ | ****⋁ | ||||
| [38] | ****⋁ | ****⋁ | ****⋁ | ****⋁ | |||||
| [32] | ***⋁ | ***⋁ | ***⋁ | ||||||
| [39] | ****⋁ | ****⋁ | ****⋁ | ||||||
| [37] | #⋀ | #⋀ | |||||||
| [33] | ***± | ***± | ***± | ***± | ***± | ||||
| [19] | *⋁ | *⋁ | |||||||
| [20] | *⋁ | ||||||||
| [21] | *⋁ | ||||||||
| [22] | *⋁ | *⋁ | |||||||
| [23] | *⋁ | *⋁ | |||||||
| [24] | *⋁ | ||||||||
| [25] | *⋁ | ||||||||
| [26] | *⋁ | ||||||||
| [27] | *⋁ | ||||||||
| [34] | ***⋁ | ***⋁ | |||||||
| [28] | *⋁ | ||||||||
| [29] | *⋁ | *⋁ | |||||||
| [30] | *⋁ | ||||||||
| [35] | *⋁ | *⋁ | *⋁ | *⋁ | |||||
| Total (n) | 14 | 8 | 6 | 2 | 8 | 4 | 5 | 3 | 4 |
| Reference## | Delayed treatment (alteplase/thrombolysis/thrombectomy/consultation) | Thrombotic/ blood and immune system complications | NIHSS (stroke severity) | mRS (disability) | Mortality | The D-dimer levels | Comorbidities | ARDS | Prolonged hospitalization |
|---|---|---|---|---|---|---|---|---|---|
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| [ | |||||||||
| Total ( |
Note(s): NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, ARDS Acute Respiratory Distress Syndrome; ## One study reported ≥ one impact; #˄ Outcome significantly improved (no comparison group); *⋁ Outcome significantly worse compared to stroke patients without the diagnosis of COVID-19; ***⋁ Outcome significantly worse compared to stroke patients with the diagnosis of COVID-19; ***± Outcome combined results compared to stroke patients with the diagnosis of COVID-19; ****⋁ Outcome significantly worse compared to non-stroke patients with the diagnosis of COVID-19